Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-19 Purchase |
2021-10-20 7:37 pm |
MiNK Therapeutics Inc. | INKT | AGENUS INC 10% Owner |
1,400,000 | $12 | $16,800,000 | 26,332,958 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-09 Option Award |
2022-03-11 4:12 pm |
N/A 2032-03-09 |
MiNK Therapeutics Inc. | INKT | Baldoni John Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:11 pm |
N/A 2032-03-09 |
MiNK Therapeutics Inc. | INKT | Ryan Barbara Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:09 pm |
N/A 2032-03-09 |
MiNK Therapeutics Inc. | INKT | Corvese Brian Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:08 pm |
N/A 2032-03-09 |
MiNK Therapeutics Inc. | INKT | WIINBERG ULF Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-12-28 Ownership |
2022-02-14 4:05 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | ARMEN GARO H Director |
360,000 | $0 | 1,866,400 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 5:20 pm |
N/A 2032-01-21 |
MiNK Therapeutics Inc. | INKT | Buell Jennifer See Remarks |
679,800 | $0 | 679,800 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 5:19 pm |
N/A 2032-01-21 |
MiNK Therapeutics Inc. | INKT | van Dijk Marcus Antonius Chief Technology Officer |
62,500 | $0 | 62,500 (Direct) |
View |
| 2021-10-19 Conversion |
2021-10-20 7:37 pm |
2021-10-19 2022-07-01 |
MiNK Therapeutics Inc. | INKT | AGENUS INC 10% Owner |
5,451,958 | $0 | 26,332,958 (Direct) |
View |
Ownership |
2021-10-20 7:05 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | Corvese Brian Director |
0 | $0 | 654,005 (Direct) |
View |
Ownership |
2021-10-20 7:02 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | AGENUS INC 10% Owner |
0 | $0 | 24,932,958 (Direct) |
View |
Ownership |
2021-10-20 7:01 pm |
N/A 2031-09-15 |
MiNK Therapeutics Inc. | INKT | Ryan Barbara Director |
0 | $0 | 41,745 (Direct) |
View |
Ownership |
2021-10-20 6:59 pm |
N/A 2029-11-14 |
MiNK Therapeutics Inc. | INKT | FLAMENBAUM WALTER MD Director |
0 | $0 | 347,875 (Direct) |
View |
Ownership |
2021-10-20 6:59 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | WIINBERG ULF Director |
0 | $0 | 438,322 (Direct) |
View |
Ownership |
2021-10-20 6:57 pm |
N/A 2031-02-11 |
MiNK Therapeutics Inc. | INKT | Baldoni John Director |
0 | $0 | 41,745 (Direct) |
View |
Ownership |
2021-10-20 6:57 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | ARMEN GARO H Director |
0 | $0 | 3,812,710 (Direct) |
View |
Ownership |
2021-10-20 6:56 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | KLASKIN CHRISTINE M Treasurer |
0 | $0 | 55,660 (Direct) |
View |
Ownership |
2021-10-20 6:55 pm |
N/A 2031-02-11 |
MiNK Therapeutics Inc. | INKT | Behner Peter Director |
0 | $0 | 41,745 (Direct) |
View |
Ownership |
2021-10-20 6:53 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | Buell Jennifer See Remarks |
0 | $0 | 1,808,950 (Direct) |
View |
Ownership |
2021-10-20 6:52 pm |
N/A 2028-11-08 |
MiNK Therapeutics Inc. | INKT | van Dijk Marcus Antonius Chief Technology Officer |
0 | $0 | 236,554 (Direct) |
View |